Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, ...

Please provide your email address to receive an email when new articles are posted on . Approximately 70% of previous nonresponders to the HBV vaccine developed a response after HCV treatment and cure ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk of severe liver complications, including ...

Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, ...

SAN FRANCISCO, Dec. 12, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oligonucleotide-based ...

Medically reviewed by Steffini Stalos, DO Key Takeaways There is currently no cure for hepatitis B, but researchers are working on it.The unique structure of hepatitis B's DNA makes it hard to treat ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...

Please provide your email address to receive an email when new articles are posted on . The cumulative probability of functional cure was 14.53% at a mean age of 25.75 years. The annual cure rate was ...

Detectable serum HBV RNA in chronic hepatitis B patients with undetectable viral DNA was associated with a 3.2-fold higher ...

A NEW point-of-care fingerstick test detects hepatitis B virus (HBV) within one hour, a 2026 diagnostic study has found. The accuracy and reliability of the Xpert HBV Viral Load test, using ...

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...